Do All Medical Devices Require Clinical Trials for Overseas Registration?

No. Not all medical devices require clinical trials for overseas registration. In most countries, the clinical evidence requirement is determined by the product's risk classification, degree of innovation, availability of similar or predicate devices, existing clinical data, literature evidence, post-market data, and performance verification results. Some products may be supported through clinical evaluation, equivalence demonstration, literature, or prior marketing experience; high-risk, innovative, implantable, life-supporting, or strongly claimed products may require a higher level of clinical evidence or even local clinical trials.

Prepared by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practice, and the AIMEILI medical device international registration knowledge base.

FAQ Article

Do All Medical Devices Require Clinical Trials for Overseas Registration?

Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00

This article focuses on international medical device registration, documentation preparation, compliance pathways, and post-market maintenance, outlining the issues companies need to prioritize in actual projects.

Content Structure

• Key Summary
• Decision Logic
• Documentation Priorities
• Common Misunderstandings
• AIMEILI View
• Continue Reading
• Applicability Boundaries

Key Summary

Not all medical devices require clinical trials for overseas registration. In most countries, the clinical evidence requirement is determined by the product's risk classification, degree of innovation, availability of similar or predicate devices, existing clinical data, literature evidence, post-market data, and performance verification results. Some products may be supported through clinical evaluation, equivalence demonstration, literature, or prior marketing experience; high-risk, innovative, implantable, life-supporting, or strongly claimed products may require a higher level of clinical evidence or even local clinical trials.

Decision Logic

Companies should first assess the target market, registration pathway, commercial launch plan, and current documentation status in the same table. Without an initial pathway assessment, subsequent work on local agents, labels, testing, clinical evidence, or certificate maintenance is prone to repeated rework.

Documentation Priorities

Documentation preparation should focus on checking whether the product description, intended use, model/specifications, risk management, performance verification, clinical or evaluation evidence, labels and instructions for use, quality system evidence, authorization documents, and post-market maintenance arrangements are mutually consistent.

Common Misunderstandings

A common misunderstanding is focusing only on 'whether it can be submitted' while ignoring classification determination, documentation consistency, product claims, post-market responsibilities, and target-country localization requirements. The earlier a gap assessment is conducted in a registration project, the lower the risk of subsequent deficiency corrections and rework.

AIMEILI View

AIMEILI recommends that companies incorporate this question into a unified assessment at the project initiation stage, rather than handling it ad hoc before submission. A more prudent approach is to first complete product classification, documentation gap analysis, target-country prioritization, local responsible entity, and post-market maintenance arrangements, and then develop an executable registration plan.

Continue Reading

• Previous: Can Existing English Labels Always Be Used in the Target Country?
• Next: What Does Clinical Evaluation Documentation Usually Focus On?

Recommended Reading

• How to Prepare a Medical Device Registration Documentation Checklist for Indonesia?
• How Is the Singapore HSA Medical Device Registration Process Conducted?
• What Documentation Is Required for Medical Device Import Registration in Vietnam?
• How to Select a Local Agent for Medical Device Registration in the Middle East?
• Malaysia MDA Medical Device Registration Documentation Checklist?
• Saudi SFDA Medical Device Registration Documentation Checklist?

Return to FAQ Center | News and Insights | Contact AIMEILI

Content Review and Applicability Boundaries

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI Medical Device International Registration Project Team

Source principle: Priority is given to official regulatory authorities, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as supplementary judgment.

Applicability boundaries: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements of the target country's regulatory authority, testing conclusions, or legal advice.